Aclaris Therapeutics, Inc 10-K for FY2021
Aclaris Therapeutics, Inc. (ACRS)
10-K
2022-02-24
For: 2021-12-31
View Original
Added on
April 08, 2026
About this 10-K
Aclaris Therapeutics, Inc filed this 10-K on February 24, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $6.76M
- up 4.3% from $6.48M a year earlier
- Net loss
- $90.87M
- compared with a net loss of $51.02M a year earlier
- Diluted EPS
- -$1.60
- compared with -$1.20 a year earlier